Adagene Inc. (FRA:978)

Germany · Delayed Price · Currency is EUR

3.500

+0.040 (1.16%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceuticals	103.20K	18.11M	9.29M	10.18M	700.91K
Pharmaceuticals Growth	-99.43%	94.90%	-8.67%	1351.71%	46.02%
Total	103.20K	18.11M	9.29M	10.18M	700.91K
Total Growth	-99.43%	94.90%	-8.67%	1351.71%	46.02%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
PRC	103.20K	18.11M	9.29M	10.18M	700.91K
PRC Growth	-99.43%	94.90%	-8.67%	1351.71%	46.02%
Total	103.20K	18.11M	9.29M	10.18M	700.91K
Total Growth	-99.43%	94.90%	-8.67%	1351.71%	46.02%

Source: S&P Global Market Intelligence.